These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 2641464

  • 1. Combined treatment of autoimmune MRL/Mp-lpr/lpr mice with cholera toxin plus irradiation. Combined treatment of autoimmune MRL/l mice.
    Fan JL, Himeno K, Hussain A, Nomoto K.
    Biotherapy; 1989; 1(2):97-102. PubMed ID: 2641464
    [Abstract] [Full Text] [Related]

  • 2. Treatment of autoimmune MRL/Mp-lpr/lpr mice with cholera toxin.
    Fan JL, Himeno K, Tsuru S, Nomoto K.
    Clin Exp Immunol; 1987 Oct; 70(1):94-101. PubMed ID: 3500817
    [Abstract] [Full Text] [Related]

  • 3. Comparison of immunological effects of cholera toxin on autoimmune MRL/lpr and BXSB mice.
    Zhou NN, Nakai S, Oka M, Nagasawa H, Himeno K.
    Microbiol Immunol; 1992 Oct; 36(7):745-56. PubMed ID: 1406377
    [Abstract] [Full Text] [Related]

  • 4. Combined treatment of autoimmune MRL/MP-lpr/lpr mice with a herbal medicine, Ren-shen-yang-rong-tang (Japanese name: Ninjin-youei-to) plus suboptimal dosage of prednisolone.
    Zhou NN, Nakai S, Kawakita T, Oka M, Nagasawa H, Himeno K, Nomoto K.
    Int J Immunopharmacol; 1994 Oct; 16(10):845-54. PubMed ID: 7843856
    [Abstract] [Full Text] [Related]

  • 5. Effect of cyclophosphamide on lymphokine production in MRL/lpr.Yaa mice.
    Kamada H, Takaoka Y, Kitagaki K, Nagai H.
    Inflamm Res; 1995 Nov; 44(11):491-8. PubMed ID: 8597884
    [Abstract] [Full Text] [Related]

  • 6. Combined treatments with Ninjin-youei-to (Ren-shen-yang-rong-tang) plus a suboptimal dose of prednisolone on autoimmune nephritis in MRL/lpr mice.
    Nakai S, Kawakita T, Himeno K, Nomoto K.
    Int J Immunopharmacol; 1998 Jun; 20(6):275-84. PubMed ID: 9754675
    [Abstract] [Full Text] [Related]

  • 7. Treatment of autoimmune MRL/Ipr mice with monoclonal antibody to Thy-1.2: a single injection has sustained effects on lymphoproliferation and renal disease.
    Seaman WE, Wofsy D, Greenspan JS, Ledbetter JA.
    J Immunol; 1983 Apr; 130(4):1713-8. PubMed ID: 6187819
    [Abstract] [Full Text] [Related]

  • 8. The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/MP-lpr/lpr mice.
    Huang FP, Feng GJ, Lindop G, Stott DI, Liew FY.
    J Exp Med; 1996 Apr 01; 183(4):1447-59. PubMed ID: 8666903
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of several kinds of drugs on the development of autoimmunity in MRL/Mp-lpr/lpr mice; lack of correlation between the suppression of autoantibody production and prevention of autoimmune disease.
    Mihara M, Ohsugi Y.
    J Pharmacobiodyn; 1989 Feb 01; 12(2):100-6. PubMed ID: 2526211
    [Abstract] [Full Text] [Related]

  • 11. Spontaneous production of interleukin 3 by T lymphocytes from autoimmune MRL/MP-lpr/lpr mice.
    Palacios R.
    Eur J Immunol; 1984 Jul 01; 14(7):599-605. PubMed ID: 6430708
    [Abstract] [Full Text] [Related]

  • 12. Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis.
    Faust J, Menke J, Kriegsmann J, Kelley VR, Mayet WJ, Galle PR, Schwarting A.
    Arthritis Rheum; 2002 Nov 01; 46(11):3083-95. PubMed ID: 12428253
    [Abstract] [Full Text] [Related]

  • 13. Successful treatment of autoimmune manifestations in MRL/l and MRL/n mice using total lymphoid irradiation (TLI).
    Moscovitch M, Rosenmann E, Neeman Z, Slavin S.
    Exp Mol Pathol; 1983 Feb 01; 38(1):33-47. PubMed ID: 6339270
    [Abstract] [Full Text] [Related]

  • 14. In vitro and in vivo effects of pentoxifylline on macrophages and lymphocytes derived from autoimmune MRL-lpr/lpr mice.
    Hecht M, Müller M, Lohmann-Matthes ML, Emmendörffer A.
    J Leukoc Biol; 1995 Feb 01; 57(2):242-9. PubMed ID: 7852838
    [Abstract] [Full Text] [Related]

  • 15. Cellular interactions for the in vitro production of anti-chromatin autoantibodies in MRL/Mp-lpr/lpr mice.
    Fisher CL, Shores EW, Eisenberg RA, Cohen PL.
    Clin Immunol Immunopathol; 1989 Feb 01; 50(2):231-40. PubMed ID: 2521586
    [Abstract] [Full Text] [Related]

  • 16. Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice.
    Jevnikar AM, Grusby MJ, Glimcher LH.
    J Exp Med; 1994 Apr 01; 179(4):1137-43. PubMed ID: 7908320
    [Abstract] [Full Text] [Related]

  • 17. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival.
    Mannoor K, Matejuk A, Xu Y, Beardall M, Chen C.
    J Immunol; 2012 Apr 15; 188(8):3628-38. PubMed ID: 22407922
    [Abstract] [Full Text] [Related]

  • 18. Effects of early and late treatment with anti-CD4 monoclonal antibody on autoimmune disease in MRL/MP-lpr/lpr mice.
    Jabs DA, Kuppers RC, Saboori AM, Burek CL, Enger C, Lee B, Prendergast RA.
    Cell Immunol; 1994 Mar 15; 154(1):66-76. PubMed ID: 7907009
    [Abstract] [Full Text] [Related]

  • 19. 5-Azacytidine inhibits the lpr gene-induced lymphadenopathy and acceleration of lupus-like syndrome in MRL/MpJ-lpr/lpr mice.
    Yoshida H, Yoshida M, Merino R, Shibata T, Izui S.
    Eur J Immunol; 1990 Sep 15; 20(9):1989-93. PubMed ID: 1698637
    [Abstract] [Full Text] [Related]

  • 20. Effects of thymectomy or androgen administration upon the autoimmune disease of MRL/Mp-lpr/lpr mice.
    Steinberg AD, Roths JB, Murphy ED, Steinberg RT, Raveche ES.
    J Immunol; 1980 Aug 15; 125(2):871-3. PubMed ID: 7391583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.